Criteo (CRTO) Q1 2026 Earnings Transcript

Criteo reported Q1 revenue of $425 million and contribution ex-TAC of $250 million, with constant-currency contribution ex-TAC down 9% due to a $27 million Retail Media client scope reduction, though underlying contribution ex-TAC still grew 1% ex-headwind. Management cut 2026 guidance to low-single-digit declines in contribution ex-TAC at constant currency, citing softer U.S. Performance Media demand and macro weakness in Europe and APAC, while maintaining 32%-34% adjusted EBITDA margin and $190 million of planned CapEx. On the positive side, media spend topped $1 billion for the first time, liquidity was $889 million with no long-term debt, and the OpenAI partnership crossed 1,000 brands live.

Analysis

CRTO is in a transition where the market will likely over-penalize the near-term guide cut because the headline decline is dominated by a small number of client-specific retail media losses rather than broad-based product deterioration. The more important signal is that the underlying base still grew and retention remains high, which means the core ad-tech “engine” is intact; what’s broken is sales execution velocity in a handful of large U.S. accounts. That makes this less of a franchise reset and more of a timing issue, with the earliest credible re-acceleration window likely Q4 as new leadership, GO, and a broader product stack start to show up in the numbers.

The second-order effect is that CRTO’s AI narrative is strategically real but financially deferred. OpenAI/ChatGPT can be a meaningful customer acquisition and funnel-expansion vector, yet management explicitly is not underwriting it in guidance, which is exactly what you’d expect at the beginning of a monetization curve. Near term, that creates a valuation trap: investors may pay for AI optionality before the revenue bridge exists, while the current business is still exposed to discretionary retail, European travel, and large-client budget elasticity.

The contrarian read is that the market may be underestimating how much of the guidance compression is reversible once the few large accounts normalize and self-service scales. If the company can prove that the new U.S. commercial team stabilizes spend and GO adds even modest SMB contribution, the stock can rerate on improved visibility rather than on absolute growth. Conversely, if Q2 looks weak again, the bear case shifts from cyclical softness to product/channel mix deterioration, and the multiple should de-rate quickly because the AI story won’t be enough to offset an execution miss.

Key Decisions for Investors

• Buy CRTO on post-earnings weakness into the next 1-2 weeks, targeting a Q4 recovery trade; upside is driven by a likely reset in expectations if large-account spend stabilizes, with downside capped by net cash and buybacks.
• Use a call spread on CRTO (e.g., 6-9 month maturities) rather than outright stock to express the AI optionality; this limits carry cost while capturing rerating if OpenAI/GO adoption starts translating into visible pipeline conversion by year-end.
• Pair trade: long CRTO / short ROKU for 3-6 months. CRTO has a clearer path to monetizing AI-discovery traffic and cross-channel demand, while ROKU faces more direct ad-cycle volatility and less near-term monetization torque.
• For conservative portfolios, wait for the Q2 print and only add if performance media stabilizes sequentially; the risk/reward improves materially if management confirms the large-client issue was account-level rather than structural.
• If already long, hedge with a short-dated downside put spread into the next monthly print; the main risk is another guide reset before the market can price in the Q4 recovery narrative.